Overall Status

Active, not recruiting (1)

Available (1)

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Delcath Systems Inc. (2)

MelanomaPRO, Russia (1)

University of Michigan Rogel Cancer Center (1)

Collaborator

IQVIA Biotech (1)

Intervention

ipilimumab (1)

melphalan (3 mg/kg ibw) with hepatic delivery system (hds) (1)

melphalan/hds (1)

nivolumab (1)

stereotactic body radiation therapy (1)

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines (1)

Study Documents

Intervention Type

combination product (2)

drug (2)

procedure (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (2)

Expanded Access (1)

Observational (1)

melanoma, ocular

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Patients With Stage 0-IV Melanoma in Real Clinical Practice

Recruiting

Melanoma
+7 more

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines